These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4156786)

  • 1. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 2. The dopamine hypothesis of schizophrenia: a review.
    Meltzer HY; Stahl SM
    Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
    Elliott PN; Jenner P; Chadwick D; Reynolds E; Marsden CD
    J Pharm Pharmacol; 1977 Jan; 29(1):41-3. PubMed ID: 13181
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 5. Minor tranquillizers, stress and central catecholamine neurons.
    Corrodi H; Fuxe K; Lidbrink P; Olson L
    Brain Res; 1971 Jun; 29(1):1-16. PubMed ID: 5564261
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in the study of the mechanism of action of neuroleptics and amphetamine.
    Glowinski J
    J Psychiatr Res; 1974; 11():81-5. PubMed ID: 4156794
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia.
    Brown RM; Kehr W; Carlsson A
    Brain Res; 1975 Mar; 85(3):491-509. PubMed ID: 236073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 12. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic drugs and dopamine uptake inhibition.
    Halaris AE; Freedman DX
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():247-58. PubMed ID: 3829
    [No Abstract]   [Full Text] [Related]  

  • 14. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic drugs and catecholamine synapses. Summary of the session.
    Andén NE
    J Psychiatr Res; 1974; 11():97-104. PubMed ID: 4156797
    [No Abstract]   [Full Text] [Related]  

  • 17. hypobaric hypoxia: central catecholamine levels and cortical PO2 and avoidance response in rats treated with apomorphine.
    Saligaut C; Moore N; Boulu R; Plotkine M; Leclerc JL; Prioux-Guyonneau M; Boismare F
    Aviat Space Environ Med; 1981 Mar; 52(3):166-70. PubMed ID: 7225019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.
    Iversen LL; Rogawski MA; Miller RJ
    Mol Pharmacol; 1976 Mar; 12(2):251-62. PubMed ID: 4724
    [No Abstract]   [Full Text] [Related]  

  • 19. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):111-7. PubMed ID: 193050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in the activities and amounts of neurotransmitter-synthesizing enzymes in mesolimbic and other central catecholamine neurons in response to axonal injury and during collateral sprouting.
    Reis DJ; Gilad GM; Pickel VM; Ross RA; Joh TH
    Adv Biochem Psychopharmacol; 1977; 16():331-41. PubMed ID: 18886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.